GreenLight Medicines is Drug Discovery in Ireland that focus on developer business. Founded in 2014. They cover business area such as developer, cannabinoid formulation, disease area, plant-derive cannabinoid molecule, proprietary strain, medicine, plant oil extraction process, cultivation technology, medical practitioner, inflammatory disease, cancer, neurological disorder.
2014
( 12 years old in 2026 )
Developer
-
Unit 2, Block E
Nutgrove Enterprise Park
Dublin 14
Ireland
Private
developercannabinoid formulationdisease areaplant-derive cannabinoid moleculeproprietary strainmedicineplant oil extraction processcultivation technologymedical practitionerinflammatory diseasecancerneurological disorder
* We use standard office opening hours in near GreenLight Medicines's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
GreenLight Medicines is Drug Discovery business from Ireland that founded in 2014 (12 years old in 2026), GreenLight Medicines business is focusing on Developer.
GreenLight Medicines headquarter office and corporate office address is located in Unit 2, Block E Nutgrove Enterprise Park Dublin 14 Ireland.
GreenLight Medicines was founded in Ireland.
In 2026, GreenLight Medicines is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with GreenLight Medicines, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
